Do you want to read an article? Please log in or register.
Targeted therapy for rare BRAF-mutated melanoma: Updated multicenter analysis and launch of a publicly accessible online outcome database
Skin Cancer
Related content
Skin Cancer
Outcome of systemic therapy in patients with advanced rare skin cancers: A retrospective multicenter DeCOG study of 209 patients
Eur J Cancer
Ugurel S, Abu Rached N, Gambichler T, Mengoni M, Tüting T, Hassel JC, Reschke R, Lodde GC, Placke JM, Schadendorf D, Reinhardt L, Kreuter A, Gschnell M, Utikal J, Erdmann M, Dücker P, Helbig D, Franklin C, Gebhardt C, Poch G, Kähler KC, Weichenthal M, Gutzmer R, Heinzerling L, Weishaupt C, Mohr P, Thoms KM, Lang B, Schilling B, Haferkamp S, Sachse M, Welzel J, Jochims F, Raap U, Schley G, Terheyden P, Dippel E, Pöttgen C, Becker JC, Tasdogan A, Amaral T, Nanz L, Leiter U
doi: 10.1016/j.ejca.2025.115750
Leukemia
Real-world treatment and outcomes in hairy cell leukemia: a multicenter retrospective cohort including BRAF inhibitor therapy
Leuk Lymphoma
Fradin JJ, Rein L, Szabo A, Carlson KS, Badar T, Holden T, Shah S, Im A, Patel AA, Atallah E
doi: 10.1080/10428194.2026.2684259
Gastrointestinal Cancer
FOLFOXIRI/bevacizumab versus doublets/bevacizumab as initial therapy of unresectable liver-only, right-sided and/or RAS or BRAF mutated metastatic colorectal cancer: An individual patient data-based pooled analysis of randomized trials
Eur J Cancer
Antoniotti C, Marmorino F, Rossini D, Schmoll HJ, Lonardi S, Tonini G, Borelli B, Cupini S, Stein A, Moretto R, Bergamo F, Ronzoni M, Germani MM, Zaniboni A, Fazio R, De Grandis MC, Ongaro E, Masi G, Cremolini C
doi: 10.1016/j.ejca.2025.115713
Lung, Respiratory and Thoracic Cancer
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions - a real-world retrospective analysis
NPJ Precis Oncol
Leßmann ME, Saalfeld FC, Ruge L, Kauffmann-Guerrero D, Illini O, Stenzinger A, Minuth-Fuchs K, Rittmeyer A, Goetting I, Schildknecht K, Eul B, Schubart C, Rothschild SI, Grohé C, Armster K, Mohorčič K, Janzic U, Waller CF, Overbeck TR, Vesce R, Schulte H, Mauti LA, Stephan-Falkenau S, Wiesweg M, Faehling M, Gerstenmaier U, Schmid S, Kian W, Lozynskyy R, Ivanović M, Syrigos K, Simon R, Merkelbach-Bruse S, Wenzel C, Brückmann S, Herold S, Aust DE, Thomas M, Hochmair MJ, Tufman A, Rasokat A, National Network Genomic Medicine Lung Cancer (nNGM), Christopoulos P, Wermke M
doi: 10.1038/s41698-026-01486-y
Lung, Respiratory and Thoracic Cancer
Mutation testing, treatment patterns, and outcomes in patients with unresectable stage III EGFR-mutated non-small cell lung cancer treated with chemoradiotherapy: Final analysis of a global real-world study
Lung Cancer
Ahn MJ, Lin SH, Yang CT, Lee JB, Neal JW, Okishio K, Nishino K, Smith D, Rauter M, Jimenez M, Nasirova F, Kim Y
doi: 10.1016/j.lungcan.2025.108748
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Clinical Outcomes of Compound EGFR Mutations in Non-Small Cell Lung Cancer: A National, Retrospective, Multicenter Study
★ 1
Recommended by
Dr. med. Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Clin Lung Cancer
Atlagh L, Toublanc AC, Roch B, Marinello A, Ruuth-Praz J, Cousin S, Chouaid C, Basset C, Evrard S, Duruisseaux M, Girard N, Durand K, Mazières J, Brindel A
doi: 10.1016/j.cllc.2025.06.005
Skin Cancer
Safety of Multi-Omics-Guided Therapy in Advanced Melanoma: A Matched Comparative Cohort Analysis
JCO Precis Oncol
Gosztonyi B, Mehra T, Gut G, Miglino N, Ring A, Martínez Gómez JM, Ramelyte E, Sobottka B, Koelzer VH, Moch H, Levesque MP, Mangana J, Dummer R, Boos L, Wicki A, Tumor Profiler Consortium
doi: 10.1200/PO-25-00896
Leukemia
Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 Patients
Am J Hematol
Molica M, Miralles G, Dillon R, Annunziata M, Basheer F, Bergua JM, Calmet FV, Campbell V, Cetin D, Cimino G, Ciotti G, Corbingi A, De Fazio L, Erol HA, Federico V, Gil C, Gulu YM, Malcorra AB, Mariani S, Mazzone C, Mulè A, Musuraca G, Khan A, Norata M, O'Nions J, Palumbo FE, Papayannidis C, Piccioni AL, Rubio MTO, Sanchez-Tovar J, Serin I, Serrao A, Sevindik OG, Sucato G, Urbano MA, Vetro C, Vives S, Rossi M, Martelli MP, Montesinos P, Othman J, Perrone S
doi: 10.1002/ajh.70142
Lung, Respiratory and Thoracic Cancer
Real-world clinical characteristics and outcomes in patients with HER2-mutant non-small cell lung cancer (NSCLC) who received second-line treatment: A nationwide database analysis in Japan
Lung Cancer
Uehara Y, Ikegami M, Kohsaka S, Kimura H, Mizushima M, Okuma Y
doi: 10.1016/j.lungcan.2026.109491